Table 1

Group comparison by median changes in CDAI at indicated time points compared with the previous CDAI score

	Time point (months)
	1	2	3	6
Azathioprine	111	−9	5	18
MMF	147	−6	32	−21
p Value	0.0103^1-150	0.8312	0.3957	0.0548

p values are based on two sample Wilcoxon tests.
Positive changes indicate decreases in CDAI scores.
↵1-150 Significant at multiple levels, α=5%.